[ALK inhibitor]

Nihon Yakurigaku Zasshi. 2013 Jul;142(1):48-50. doi: 10.1254/fpj.142.48.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Clinical Trials as Topic
  • Crizotinib
  • Drug Discovery*
  • Humans
  • Lung Neoplasms / genetics
  • Molecular Targeted Therapy*
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / pharmacology*
  • Pyrazoles / therapeutic use*
  • Pyridines / pharmacology*
  • Pyridines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptor Protein-Tyrosine Kinases / genetics*
  • Receptor Protein-Tyrosine Kinases / physiology
  • Small Cell Lung Carcinoma / genetics

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases